Dudediligence.

QuidelOrtho Corporation

QDELNASDAQ · In Vitro & in Vivo Diagnostic Substances
Write an idea

Price
FilingsNewest: 8-K, Material agreementSep 23 →Insiders6 insiders bought $1.2M in 8 open-market buys. 1 insider sold $111,963 in 1 sale, with no 10b5-1 plan named.→HoldersBlackRock 16.4%FMR 10.8%Newtyn 9.7%→PeersClosest companies: FLGT, WGS, BDSX→

From the filings

Figures

Revenue
$2.67Blast 12 months
Net income
−$1.05Blast 12 months
Operating cash flow
$6.6Mlast 12 months
Cash and equivalents
$123.4Mat the last balance sheet
Total debt
$2.89Bat the last balance sheet
Shares outstanding
68.3M shareson issue
Every year and quarter →